Primary Progressive Multiple Sclerosis -
-40% koodiga BOOKS
Saadetis 12-18 tööpäeva jooksul
30-päevane tagastamisõigus
"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in ... Täielik kirjeldus
Võib-olla meeldib sulle ka
TOP
The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture
-40% koodiga BOOKS
Laos
TOP
No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model
-40% koodiga BOOKS
Meie tarnija laos
TOP
Maybe You Should Talk to Someone: a therapist, her thearapist, and our lives revealed
-40% koodiga BOOKS
Meie tarnija laos
TOP
Aids to the Examination of the Peripheral Nervous System
-40% koodiga BOOKS
Meie tarnija laos
TOP
Harrison's Principles of Internal Medicine (Vol.1 & Vol.2)
Stephen Hauser, Joseph Loscalzo, Steven Holland, Dan Longo, J. Larry Jameson, Dennis Kasper, Carol Langford, Anthony Fauci
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Checklist Manifesto: How to Get Things Right
-40% koodiga BOOKS
Meie tarnija laos
TOP
How Not To Die: Discover the foods scientifically proven to prevent and reverse disease
-40% koodiga BOOKS
Meie tarnija laos
TOP
Lifespan: Why We Age - and Why We Don't Have To
-40% koodiga BOOKS
Meie tarnija laos
TOP
Vademecum Metabolicum: Diagnosis and Treatment of Inborn Errors of Metabolism Forword by William L. Nyhan, San Diego, USA
Johannes Zschocke, Georg F. Hoffmann
-40% koodiga BOOKS
Meie tarnija laos
TOP
ROAR: How to Match Your Food and Fitness to Your Unique Female Physiology for Optimum Performance, Great Health, and a Strong, Lean Body for Life
-40% koodiga BOOKS
Meie tarnija laos
TOP
Cellular and Molecular Immunology
Sarah Henrickson, Abul K. Abbas, Andrew H. Lichtman, Shiv Pillai
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Autistic Burnout Workbook: Your Guide to Your Personal Recovery Plan
-40% koodiga BOOKS
Meie tarnija laos
TOP
McGee's Evidence-Based Physical Diagnosis
-40% koodiga BOOKS
Meie tarnija laos
TOP
Physics, Pharmacology and Physiology for Anaesthetists: Key Concepts for the FRCA
Matthew E. Cross, Emma V. E. Plunkett
-40% koodiga BOOKS
Meie tarnija laos
TOP
Oxford Handbook of Clinical Medicine
Peter Hateley, Iain McGurgan, Ian B. Wilkinson, Tim Raine, Dearbhla Kelly, Kate Wiles
-40% koodiga BOOKS
Meie tarnija laos
TOP
Pocket Guide to Teaching for Clinical Instructors
-40% koodiga BOOKS
Meie tarnija laos
TOP
Oxford Handbook of Critical Care
Andrew Webb, Mervyn Singer, Alice Carter
-40% koodiga BOOKS
Meie tarnija laos
Kirjeldus
"Why are there no effective treatments for my condition? Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials? Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. " Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin ical trials have excluded PPMS patients on two counts. Clinical worsening devel ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi ence suggests that the results may not be dramatic.
Lisateave
| Kirjastaja | Springer Milan |
|---|---|
| Series | Topics in Neuroscience |
| Väljalaskeaasta | 2012 |
| Kaanetüüp | Pehme kaanega |
| EAN | 9788847022362 |